Featuring perspectives from Dr Dana M Chase, Ms Sarah Karpen, Dr J Alejandro Rauh-Hain and Ms Jaclyn Shaver, moderated by Dr Chase, including the following topics:

• Introduction: Biology of Endometrial Cancer (EC) (0:00)
• First-Line Therapy for Advanced or Recurrent EC (14:15)
• Potential Benefits of PARP Inhibition Combined with Immunotherapy in Advanced EC (35:13)
• Role of Lenvatinib/Pembrolizumab in the Management of Progressive Advanced EC (57:48)
• Other Nursing Considerations in the Care of Patients with Advanced EC (1:17:28)

NCPD information and select publications

Featuring perspectives from Dr Deborah K Armstrong and Dr David M O’Malley, including the following topics:

• Introduction (0:00)
• PARP Inhibitors and Strategies Targeting Folate Receptor Alpha in Advanced Ovarian Cancer — Dr Armstrong (4:37)
• Other Novel Agents and Strategies for the Treatment of Advanced Ovarian Cancer — Dr O’Malley (35:18)

CME information and select publications

Featuring perspectives from Dr Joyce F Liu, Dr David M O’Malley and Dr Brian M Slomovitz, moderated by Dr O’Malley, including the following topics:

• Introduction (0:00)
• Strategies to Identify Patients with HER2-Positive Gynecologic Cancers — Dr Liu (2:52)
• Available Data with and Practical Application of HER2-Targeted Therapy in Advanced Gynecologic Cancers — Dr Slomovitz (25:16)
• Identification and Management of Adverse Events with Trastuzumab Deruxtecan — Dr O’Malley (1:00:31)

CME information and select publications